BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 33999163)

  • 21. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
    Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
    Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
    Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
    J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation.
    Shah SJ; Eckman MH; Aspberg S; Go AS; Singer DE
    Ann Intern Med; 2018 Oct; 169(8):517-527. PubMed ID: 30264130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
    Abdel-Qadir H; Singh SM; Pang A; Austin PC; Jackevicius CA; Tu K; Dorian P; Ko DT
    JAMA Cardiol; 2021 Aug; 6(8):918-925. PubMed ID: 34009232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inequality in oral anticoagulation use and clinical outcomes in atrial fibrillation: a Danish nationwide perspective.
    Christesen AMS; Vinter N; Mortensen LS; Fenger-Grøn M; Johnsen SP; Frost L
    Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):189-199. PubMed ID: 30102321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
    J Am Heart Assoc; 2022 Mar; 11(6):e024119. PubMed ID: 35229612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CHA
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
    J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
    Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy.
    Søgaard M; Skjøth F; Nielsen PB; Smit J; Dalager-Pedersen M; Larsen TB; Lip GYH
    JAMA Netw Open; 2022 May; 5(5):e2213945. PubMed ID: 35616941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral anticoagulant therapy in older medical in-patients with atrial fibrillation: a prospective cohort observational study.
    Bo M; Li Puma F; Badinella Martini M; Falcone Y; Iacovino M; Grisoglio E; Menditto E; Fonte G; Brunetti E; Isaia GC; D'Ascenzo F; Gaita F
    Aging Clin Exp Res; 2017 Jun; 29(3):491-497. PubMed ID: 27100358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
    Mentias A; Shantha G; Chaudhury P; Vaughan Sarrazin MS
    JAMA Netw Open; 2018 Sep; 1(5):e182870. PubMed ID: 30646182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.